Study of the Depth of Anesthesia on Postoperative Clinical Outcome in Patients With Supratentorial Tumor

NCT03033693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1461

Last updated 2022-01-14

No results posted yet for this study

Summary

Recent studies have shown that deep anesthesia is associated with poor outcome. There is still lack of randomized controlled trials with large sample size on the effect of depth of anesthesia on the postoperative outcomes in patients undergoing brain tumor resection. The investigators are performing a randomized and parallel group trial. The aim of the study is to determine whether there is a causal relationship between the depth of anesthesia and postoperative clinical outcome in patients undergoing supratentorial tumor surgery.

Conditions

  • Anesthesia, Brain Tumor, Supratentorial,Outcome

Interventions

OTHER

Bispectral index will be targeted at 50

The depth of general anesthesia will be monitored by bispectral index (BIS) at 50.

OTHER

Bispectral index will be targeted at 35

The depth of general anesthesia will be monitored by bispectral index (BIS) at 35.

Sponsors & Collaborators

  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • Guiyang Jinyang Hospital

    collaborator UNKNOWN
  • Beijing Sanbo Brain Hospital

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Anhui Provincial Hospital

    collaborator OTHER_GOV
  • Guangdong 999 Brain Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Ruquan Han, M.D., Ph.D · Department of Anesthesiology, Beijing Tian Tan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-11-04
Completion
2019-11-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03033693 on ClinicalTrials.gov